About

Shirley Recipon M.S. R.P.A.

Founder and Principal

Shirley started Recipon Consulting in 2013. She focuses on Understanding a client’s innovations, Working with teams to capture each client’s cutting edge inventions, Collaborating with stake holders, business partners, Building consensus and Achieving each client’s goals and objectives.

Shirley has a multi-platform research background in cell and molecular biology, genetics, chemistry, physics and mechanical devices within industry and leading academic and government research institutions. She has professional experience in industrial settings conducting chemical analysis on preclinical pharmaceuticals, metabolic studies, genetic analyses, examining cellular processes and physical chemistry evaluations and engineering improvements for devices. Her post-graduate research was conducted at The Johns Hopkins University in pharmacogenomics and at the NIH in immunology and at NIH/NCBI annotating the GenBank database and performing sequence analyses using state of the art bioinformatic tools, and has extensive practical industrial experience in analytical and physical chemistry, prior to entering the Intellectual Property profession as a U.S. Registered Patent Agent with the USPTO.

She has more than 20 years Intellectual Property (IP) experience dedicated to providing strategic, global IP protection for early stage, start-up, established and Fortune 500 companies, such as Incyte Corporation, Life Technologies, Dupont Industrial Biosciences and Amgen for example. Recent IP filings include sequence-based discoveries, biomarkers, diagnostic methods, NGS, stem cell innovations, biologics and microbiome-based therapeutics. Shirley is results oriented to deliver domestic and international patent applications and patents aligned with each client’s business goals and objectives. Shirley is an expert in the filing and prosecution of US provisional applications, US utility applications, US Track One (Prioritized Examination) applications, and PCT (international) applications.